Clinical Trials Insight: 700029298
Phase of Trial: Phase I
Latest Information Update: 06 Jan 2009
At a glance
- Drugs Brincidofovir (Primary)
- Indications Smallpox
- Focus Adverse reactions
- Sponsors Chimerix
- 06 Jan 2009 Status changed from active, no longer recruiting to completed according to a Chimerix media release.
- 14 Dec 2007 New trial record.
- 06 Nov 2007 Interim results were reported at AASLD 2007.